UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Anticoagulant activity of apixaban can be estimated by multiple regression analysis

Journal of arrhythmia, 2020-12, Vol.36 (6), p.1032-1038

2020

Volltextzugriff (PDF)

The Role of the Pharmacist in Clinical Settings (13): Estimation of Anticoagulant Activity of an Oral Anticoagulant Based on Patient Data from Nippon Medical School Hospital: 付属病院の患者データに基づいた経口抗凝固薬の抗凝固作用の推定

Nihon Ika Daigaku Igakkai zasshi, 2024-02, Vol.20 (1), p.4-9

2024

Volltextzugriff (PDF)

The Role of the Pharmacist in Clinical Settings (13): Estimation of Anticoagulant Activity of an Oral Anticoagulant Based on Patient Data from Nippon Medical School Hospital

Nihon Ika Daigaku Igakkai Zasshi, 2024/02/20, Vol.20(1), pp.4-9

2024

Volltextzugriff (PDF)

Effects of Excimer Irradiation Treatment on Thermocompression Au--Au Bonding

Japanese Journal of Applied Physics, 2010-06, Vol.49 (6), p.06GN12-06GN12-4

2010

Volltextzugriff (PDF)

Discovery of highly potent and selective biphenylacylsulfonamide-based β3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the β2-adrenergic receptor: Part 6

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (16), p.4679-4683

2009

Volltextzugriff (PDF)

Discovery of Highly Potent and Selective Biphenylacylsulfonamide-Based β3-Adrenergic Receptor Agonists and Evaluation of Physical Properties as Potential Overactive Bladder Therapies: Part 5

Journal of medicinal chemistry, 2009-05, Vol.52 (9), p.3063-3072

2009

Volltextzugriff (PDF)

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human β3-adrenergic receptor agonists: Part IV

Bioorganic & medicinal chemistry letters, 2008-09, Vol.18 (18), p.5037-5040

2008

Volltextzugriff (PDF)

Effects of Vacuum Ultraviolet Surface Treatment on the Bonding Interconnections for Flip Chip and 3-D Integration

IEEE transactions on electronics packaging manufacturing, 2010-07, Vol.33 (3), p.212-220

2010

Volltextzugriff (PDF)

臨床現場における薬剤師の役割（13）: 付属病院の患者データに基づいた経口抗凝固薬の抗凝固作用の推定

日本医科大学医学会雑誌, 2024/02/20, Vol.20(1), pp.4-9

2024

Volltextzugriff (PDF)

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human β3-Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I

Journal of medicinal chemistry, 2008-03, Vol.51 (6), p.1925-1944

2008

Volltextzugriff (PDF)

Fluxless Bonding Using Vacuum Ultraviolet and Formic Acid for 3D Interconnects

MRS proceedings, 2010, Vol.1249 (1), Article 1249-F09-04

2010

Volltextzugriff (PDF)

Discovery of a Novel Series of Benzoic Acid Derivatives as Potent and Selective Human β3 Adrenergic Receptor Agonists with Good Oral Bioavailability. 3. Phenylethanolaminotetraline (PEAT) Skeleton Containing Biphenyl or Biphenyl Ether Moiety

Journal of medicinal chemistry, 2008-08, Vol.51 (15), p.4804-4822

2008

Volltextzugriff (PDF)

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Highly Potent and Selective Human β3 Adrenergic Receptor Agonists with Good Oral Bioavailability. Part II

Journal of medicinal chemistry, 2008-07, Vol.51 (13), p.4002-4020

2008

Volltextzugriff (PDF)

New Chip Joint Method for Silicon Die Bonding

Journal of Smart Processing, 2012/05/20, Vol.1(3), pp.120-125

2012

Volltextzugriff (PDF)

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV

Bioorganic & medicinal chemistry letters, 2008-09, Vol.18 (18), p.5037-5040

2008

Volltextzugriff (PDF)

Discovery of a Novel Series of Benzoic Acid Derivatives as Potent and Selective Human β 3 Adrenergic Receptor Agonists with Good Oral Bioavailability. 3. Phenylethanolaminotetraline (PEAT) Skeleton Containing Biphenyl or Biphenyl Ether Moiety

Journal of medicinal chemistry, 2008-08, Vol.51 (15), p.4804-4822

2008

Volltextzugriff (PDF)

Discovery of Highly Potent and Selective Biphenylacylsulfonamide-Based β 3 -Adrenergic Receptor Agonists and Evaluation of Physical Properties as Potential Overactive Bladder Therapies: Part 5

Journal of medicinal chemistry, 2009-05, Vol.52 (9), p.3063-3072

2009

Volltextzugriff (PDF)

Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I

Journal of medicinal chemistry, 2008-03, Vol.51 (6), p.1925-1944

2008

Volltextzugriff (PDF)

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human β 3 -Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I

Journal of medicinal chemistry, 2008-03, Vol.51 (6), p.1925-1944

2008

Volltextzugriff (PDF)

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta sub(3)-adrenergic receptor agonists: Part IV

Bioorganic & medicinal chemistry, 2008-09, Vol.18 (18), p.5037-5040

2008

Volltextzugriff (PDF)

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Highly Potent and Selective Human fi3 Adrenergic Receptor Agonists with Good Oral Bioavailability. Part II

Journal of medicinal chemistry, 2008, Vol.51 (13), p.4002-4020

2008

Volltextzugriff (PDF)

Discovery of highly potent and selective biphenylacylsulfonamide-based beta sub(3)-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta sub(2)-adrenergic receptor: Part 6

Bioorganic & medicinal chemistry letters, 2009-08, Vol.19 (16), p.4679-4683

2009

Volltextzugriff (PDF)

Discovery of highly potent and selective biphenylacylsulfonamide-based β 3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the β 2-adrenergic receptor: Part 6

Bioorganic & medicinal chemistry letters, 2009, Vol.19 (16), p.4679-4683

2009

Volltextzugriff (PDF)

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human β 3-adrenergic receptor agonists: Part IV

Bioorganic & medicinal chemistry letters, 2008, Vol.18 (18), p.5037-5040

2008

Volltextzugriff (PDF)

シリコンチップの新接合技術

スマートプロセス学会誌, 2012/05/20, Vol.1(3), pp.120-125

2012

Volltextzugriff (PDF)

1 – 25 von 29

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)

Sprache

Englisch
(26)
Japanisch
(9)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Anticoagulant activity of apixaban can be estimated by multiple regression analysis

The Role of the Pharmacist in Clinical Settings (13): Estimation of Anticoagulant Activity of an Oral Anticoagulant Based on Patient Data from Nippon Medical School Hospital: 付属病院の患者データに基づいた経口抗凝固薬の抗凝固作用の推定

The Role of the Pharmacist in Clinical Settings (13): Estimation of Anticoagulant Activity of an Oral Anticoagulant Based on Patient Data from Nippon Medical School Hospital

Effects of Excimer Irradiation Treatment on Thermocompression Au--Au Bonding

Discovery of highly potent and selective biphenylacylsulfonamide-based β3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the β2-adrenergic receptor: Part 6

Discovery of Highly Potent and Selective Biphenylacylsulfonamide-Based β3-Adrenergic Receptor Agonists and Evaluation of Physical Properties as Potential Overactive Bladder Therapies: Part 5

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human β3-adrenergic receptor agonists: Part IV

Effects of Vacuum Ultraviolet Surface Treatment on the Bonding Interconnections for Flip Chip and 3-D Integration

臨床現場における薬剤師の役割（13）: 付属病院の患者データに基づいた経口抗凝固薬の抗凝固作用の推定

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human β3-Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I

Fluxless Bonding Using Vacuum Ultraviolet and Formic Acid for 3D Interconnects

Discovery of a Novel Series of Benzoic Acid Derivatives as Potent and Selective Human β3 Adrenergic Receptor Agonists with Good Oral Bioavailability. 3. Phenylethanolaminotetraline (PEAT) Skeleton Containing Biphenyl or Biphenyl Ether Moiety

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Highly Potent and Selective Human β3 Adrenergic Receptor Agonists with Good Oral Bioavailability. Part II

New Chip Joint Method for Silicon Die Bonding

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta(3)-adrenergic receptor agonists: Part IV

Discovery of a Novel Series of Benzoic Acid Derivatives as Potent and Selective Human β 3 Adrenergic Receptor Agonists with Good Oral Bioavailability. 3. Phenylethanolaminotetraline (PEAT) Skeleton Containing Biphenyl or Biphenyl Ether Moiety

Discovery of Highly Potent and Selective Biphenylacylsulfonamide-Based β 3 -Adrenergic Receptor Agonists and Evaluation of Physical Properties as Potential Overactive Bladder Therapies: Part 5

Discovery of a novel series of biphenyl benzoic acid derivatives as potent and selective human beta3-adrenergic receptor agonists with good oral bioavailability. Part I

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Potent and Selective Human β 3 -Adrenergic Receptor Agonists with Good Oral Bioavailability. Part I

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human beta sub(3)-adrenergic receptor agonists: Part IV

Discovery of a Novel Series of Biphenyl Benzoic Acid Derivatives as Highly Potent and Selective Human fi3 Adrenergic Receptor Agonists with Good Oral Bioavailability. Part II

Discovery of highly potent and selective biphenylacylsulfonamide-based beta sub(3)-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta sub(2)-adrenergic receptor: Part 6

Discovery of highly potent and selective biphenylacylsulfonamide-based β 3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the β 2-adrenergic receptor: Part 6

Discovery of novel series of benzoic acid derivatives containing biphenyl ether moiety as potent and selective human β 3-adrenergic receptor agonists: Part IV

シリコンチップの新接合技術

Suchergebnisse filtern